Publications

Show details

With our new publication ‘Clinical Research as a Success Factor’, Interpharma presents a roadmap for strengthening Switzerland as a research location. The analysis shows that the number of clinical trials in Switzerland is declining, while other countries are investing specifically in improving conditions. As a result, Switzerland is in danger of losing its leading role as a location for medical innovation. This has noticeable consequences for research, healthcare and the economy. Interpharma wants to counteract this development and is presenting a roadmap to this end.

Show details

The pharmaceutical industry is Switzerland's economic engine, accounting for over 40% of exports and almost 10% of value added, but it is coming under increasing pressure. Price reductions, investment uncertainty, and more difficult access to innovative therapies are reducing the attractiveness of Switzerland as a pharmaceutical location. An overview of the most important figures, facts, and demands.

Show details

Roadmap for a futureproof production site Advanced pharma manufacturing: a success factor